L1 compound identified as potential treatment for Alzheimer’s disease
Drug Target Review,
A new compound named L1 has demonstrated success in mice, by reducing neuroinflammation and decreasing the levels of amyloid…
A new compound named L1 has demonstrated success in mice, by reducing neuroinflammation and decreasing the levels of amyloid…
When tested in brain cells and in a mouse model of Alzheimer's disease, a new compound significantly reduced the number of…
When tested in brain cells and in a mouse model of Alzheimer's disease, a new compound significantly reduced the number of…
While its exact causes are unknown, Alzheimer’s disease is commonly associated with clumps of toxic amyloid plaques in the brain…
When tested in brain cells and in a mouse model of Alzheimer’s disease, a new compound significantly reduced the number of…
When tested in a mouse model of Alzheimer's disease, a new compound, L1, reduced neuroinflammation, amyloid plaques and other…
CHAMPAIGN, Ill. -- When tested in brain cells and in a mouse model of Alzheimer's disease, a new compound significantly reduced…
. A Multifunctional Chemical Agent as an Attenuator of Amyloid Burden and Neuroinflammation in Alzheimer's Disease.